Ulcerative Colitis

Stay informed Receive instant email alerts when we publish new articles or reports on the topics you choose: 100% free of charge.

Unsubscribe anytime.

Absolutely no spam.

We respect your privacy.

Choose from topics like natural health, renewable energy, the environment, emerging technology and more.

Receive a free instant download of our $29 Secret Sources guide that reveals top sources for little-known health and diet solutions.

Click...

Teitelbaum, hops have a wide range of medicinal uses including acting as a muscle relaxant and inhibiting inflammation.

As a mild sedative, hops help promote sound sleep, which is a cornerstone for healing the underlying causes of pain.

"As a practitioner of comprehensive medicine, I believe we should take advantage of the best pain medicines manufactured in the laboratory as well as the best nature provides in foods and herbs." About Dr.

Teitelbaum Board certified internist Jacob Teitelbaum, MD, is the author of a landmark double-blind, randomized, placebo-controlled study published in the Journal of Chronic Fatigue Syndrome (8:2, 2001) on effective therapies for fibromyalgia and chronic fatigue syndrome.

The research showed an average improvement of 76 percent after 3 months of treatment, and a dramatic 90 percent average improvement after 2 years (p<.0001 versus placebo) using his unique comprehensive medical approach.

Close to 50 percent of those studied experienced a 133 percent increase in energy and a 58 percent reduction in pain after 3 months.

For more information, visit http://www.Vitality101.com .

About Pain Free 1-2-3 (McGraw-Hill, April 2006) Chronic pain and fatigue expert, Dr.

Jacob Teitelbaum provides over 100 natural and prescription treatments for managing muscle pain, fibromyalgia, headaches, arthritis, nerve pain, back pain and more in Pain Free 1-2-3.

This breakthrough book guides readers step-by-step on which treatm...

IBD is thought to be caused by the influence of several factors, including genetic predisposition and environmental precipitants, on the gastrointestinal tract's response to the presence of normal and pathogenic bacteria in the gut.

The result is an immune response, causing inflammation of the intestinal wall.

About Cerimon Pharmaceuticals Cerimon Pharmaceuticals, Inc.

is a biopharmaceutical company dedicated to bringing innovative therapeutics to patients with substantial, unmet medical needs.

The Company is engaged in the development and commercialization of therapeutics in the areas of autoimmune disease, inflammation and pain.

In October 2005, Cerimon closed a Series A financing of $70M in a deal led by MPM, and including Nomura Phase4 Ventures and OrbiMed Advisors.

Cerimon is headquartered in South San Francisco, CA.

For more information on Cerimon, please visit the Company's Website at http://www.cerimon.com.

SOURCE Cerimon Pharmaceuticals, Inc.

Web Site: http://www.cerimon.com Issuers of news releases and not PR Newswire are solely responsible for the accuracy of the content.Terms and conditions, including restrictions on redistribution, a...